The Secret Lives of Big Pharma's 'Thought Leaders', The Chronicle of Higher Education, 2010. ,
Accelerating the Diffusion of Innovations using Opinion Leaders, The ANNALS of the American Academy of Political and Social Science, vol.566, issue.1, pp.55-67, 1999. ,
DOI : 10.1177/0002716299566001005
Medical innovation, unmet medical need, and the drug pipeline, Can J Clin Pharmacol Vol, vol.13, issue.1, pp.85-91, 2006. ,
The Pharmaceutical Research and Manufacturers of America Code on interactions with healthcare professions The Code in Practice, 2006. ,
The Emerging Role of Medical Affairs within the Modern Pharmaceutical Company, Therapeutic Innovation & Regulatory Science, vol.35, issue.2, 2001. ,
DOI : 10.1177/009286150103500225
Has The Medical Affairs Department Left Marketing?, Pharmalot http://www.pharmalot.com/2008/03/has-the-medical-affairs-department-left-marketing ,
The Medical Science Liaison: An A To Z Guide The applied therapeutics team: an innovative model of drug information in the pharmaceutical industry. Drug Inform, J, vol.34, pp.1069-1075, 2000. ,
History and Evolution of Field-Based Medical Programs, Therapeutic Innovation & Regulatory Science, vol.34, issue.4, pp.1049-1542, 2000. ,
DOI : 10.1177/009286150003400408
Results of a survey of the Medical Scientific Liaison (MSL) function in the UK, Pharmaceutical Physician, 2012. ,
Greenberg in Conflicts of Interest: can a physician serve two masters?, Clinics in Dermatology, vol.30, pp.160-173, 2012. ,
Conflits d'intérêts : les mots ont-ils un sens ?, 2012. ,
Pharmaceutical industry sponsorship and research outcome and quality: systematic review, BMJ, vol.326, issue.7400, pp.1167-70, 2003. ,
DOI : 10.1136/bmj.326.7400.1167
Publication bias in the pulmonary/allergy literature: effect of pharmaceutical company sponsorship, Isr Med Assoc J, vol.8, pp.451-455, 2006. ,
fda.gov/ICECI/EnforcementActions/FDADebarmentList/default.htm J Dana G Loewenstein, A Social Science Perspective on gifts to Physicians from Industry, American Medical Associatio, vol.9, issue.290 2, 2003. ,
Les modifications apportées par la loi n°2011-2012 du 29 décembre 2011 au dispositif « anti-cadeaux », Qu'est-ce que le dispositif « anti-cadeaux » ? Agence Juris Media, 2012. ,
leem.org/article/transparence-des-liens Leem Press Release, 26 th Sept 2011 http://www.leem.org/installation-officielle-du-codeem- comite-de-deontovigilance-des-entreprises-du-medicament Leem Press Release, 2011. ,
Standard operating procedures (SOP) -Back Bone of Pharmaceutical Industries, 2008. ,
Exclusive: Abbott suspends giving gifts to doctors in India, Reuters, 2012. ,
Gestion des conflits d'intérêt http://www.snmrhp.org/Data/ModuleGestionDeContenu/application/495.pdf Ridker and Torres, Reported outcomes in major cardiovascular clinical trials funded by for-profit and not for-profit organizations, JAMA, vol.295, pp.2000-2005, 2006. ,
Does industry funding of Continuing Medical Education (CME) and Graduate Medical Education (GME) create bias?, 2010. ,